The Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted Therapy
Year: 2020
Type: article
Source: Clinical Genitourinary Cancer
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Gateway for Cancer Research, Bristol-Myers Squibb, Kidney Cancer Association, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, Merck, Novartis, Roche, North Carolina GlaxoSmithKline Foundation, American Society of Clinical Oncology, Alexion Pharmaceuticals, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Prometheus, Exelixis, National Comprehensive Cancer Network, European Society for Medical Oncology, Genentech, National Cancer Institute
Awards: G4142926750, G990309959
OpenAlex ID: W3010806083